Dalvand Z, Vafaeian A, Balighi K, Mahmoudi H, Dasdar S, Kianfar N
Arch Dermatol Res. 2025; 317(1):354.
PMID: 39918692
DOI: 10.1007/s00403-025-03827-6.
Smith D, Herminie V, Priya S, Shehata M
Cureus. 2025; 17(1):e78169.
PMID: 39882203
PMC: 11775635.
DOI: 10.7759/cureus.78169.
Nishibata Y, Arai S, Taniguchi M, Nakade I, Ogawa H, Kitano S
Nat Commun. 2024; 15(1):6519.
PMID: 39174512
PMC: 11341692.
DOI: 10.1038/s41467-024-50747-6.
Zhou H, Liang W, Hu H, Liu Z, Chu F, Ding G
Clin Exp Immunol. 2024; 218(2):120-135.
PMID: 39139142
PMC: 11482500.
DOI: 10.1093/cei/uxae068.
Cao B, Robinson J, Winget M, Hunt M, Carlson R, Hogan S
Clin Rheumatol. 2024; 43(9):2765-2781.
PMID: 39058400
DOI: 10.1007/s10067-024-07074-4.
Use of mesna prophylaxis in patients with cyclophosphamide-treated ANCA-associated vasculitis: cross-sectional survey of practitioners.
Joos L, Gonzalez Chiappe S, Neumann T, Mahr A
Rheumatol Int. 2024; 44(12):3099-3106.
PMID: 38935122
DOI: 10.1007/s00296-024-05620-6.
A 44-year-old man with recurrent ST-segment elevation: a case report of two presentations of Granulomatosis with Polyangiitis.
Cheng K, De Silva R
Eur Heart J Case Rep. 2024; 8(5):ytae228.
PMID: 38745729
PMC: 11091540.
DOI: 10.1093/ehjcr/ytae228.
Incidence, clinical features, management and outcomes of ANCA-associated vasculitis in pregnancy- a systematic literature review.
Ashok A, Russell L, Dey M, Kouranloo K
Sarcoidosis Vasc Diffuse Lung Dis. 2023; 40(4):e2023040.
PMID: 38126499
PMC: 10965006.
DOI: 10.36141/svdld.v40i4.15094.
ANCA-associated vasculitis: overview and practical issues of diagnosis and therapy from a European perspective.
Duarte A, Ribeiro R, Macedo A, Santos M
Porto Biomed J. 2023; 8(6):e237.
PMID: 38093794
PMC: 10715796.
DOI: 10.1097/j.pbj.0000000000000237.
Hypereosinophilic vasculitis with Raynaud phenomenon presentation: a case report.
Phuong D, The H, Duy Q
Egypt Heart J. 2023; 75(1):89.
PMID: 37851184
PMC: 10584751.
DOI: 10.1186/s43044-023-00418-6.
Management of antineutrophil cytoplasmic antibody-associated vasculitis: a review of recent guidelines.
Ahn S, Lee S
J Rheum Dis. 2023; 30(2):72-87.
PMID: 37483479
PMC: 10324935.
DOI: 10.4078/jrd.2022.0002.
Polypharmacy in US Medicare beneficiaries with antineutrophil cytoplasmic antibody vasculitis.
Cao B, Hogan S, Derebail V, Ehlert A, Thorpe C
J Manag Care Spec Pharm. 2023; 29(7):770-781.
PMID: 37404075
PMC: 10387912.
DOI: 10.18553/jmcp.2023.29.7.770.
The factors predicting development of serious infections in ANCA-associated vasculitis.
Uslu Yurteri E, Sezer S, Torgutalp M, Yayla M, Sahin Eroglu D, Okatan I
Sarcoidosis Vasc Diffuse Lung Dis. 2023; 40(2):e2023015.
PMID: 37382076
PMC: 10494754.
DOI: 10.36141/svdld.v40i2.13243.
The genomic landscape of ANCA-associated vasculitis: Distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosus.
Banos A, Thomas K, Garantziotis P, Filia A, Malissovas N, Pieta A
Front Immunol. 2023; 14:1072598.
PMID: 37051253
PMC: 10083368.
DOI: 10.3389/fimmu.2023.1072598.
Risk factors for serious infections in ANCA-associated vasculitis.
Odler B, Riedl R, Gauckler P, Shin J, Leierer J, Merkel P
Ann Rheum Dis. 2023; 82(5):681-687.
PMID: 36702528
PMC: 10176387.
DOI: 10.1136/ard-2022-223401.
Predictive Factors of Cytomegalovirus Viremia during the Clinical Course of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: A Single Center Observational Study.
Harada M, Iwabuchi R, Yamaguchi A, Aomura D, Yamada Y, Sonoda K
J Clin Med. 2023; 12(1).
PMID: 36615150
PMC: 9821060.
DOI: 10.3390/jcm12010351.
Temporal Trends in the Incidence of Hemophagocytic Lymphohistiocytosis: A Nationwide Cohort Study From England 2003-2018.
West J, Stilwell P, Liu H, Ban L, Bythell M, Card T
Hemasphere. 2022; 6(11):e797.
PMID: 36340911
PMC: 9624441.
DOI: 10.1097/HS9.0000000000000797.
Health care costs and utilization prior to diagnosis of antineutrophil cytoplasmic antibody vasculitis in Medicare beneficiaries.
Huang S, Li X, Cao B, Nguyen J, Robinson J, Derebail V
J Manag Care Spec Pharm. 2022; 28(11):1292-1303.
PMID: 36282932
PMC: 10372980.
DOI: 10.18553/jmcp.2022.28.11.1292.
Association between different infection profiles and one-year outcomes in ANCA-associated vasculitis: a retrospective study with monthly infection screening.
Xu T, Chen Z, Jiang M, Ma H, Jin K, Wang Z
RMD Open. 2022; 8(2).
PMID: 36270741
PMC: 9594583.
DOI: 10.1136/rmdopen-2022-002424.
ExploriNg DUrable Remission with Rituximab in ANCA-associatEd vasculitis (ENDURRANCE trial): protocol for a randomised controlled trial.
Dirikgil E, van Leeuwen J, Bredewold O, Ray A, Jonker J, Soonawala D
BMJ Open. 2022; 12(9):e061339.
PMID: 36130755
PMC: 9494556.
DOI: 10.1136/bmjopen-2022-061339.
